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Abstract
Computational vaccinology or vaccine informatics is an interdisciplinary field that addresses scientific and clinical
questions in vaccinology using computational and informatics approaches. Computational vaccinology overlaps
with many other fields such as immunoinformatics, reverse vaccinology, postlicensure vaccine research,
vaccinomics, literature mining, and systems vaccinology. The second ISV Pre-conference Computational
Vaccinology Workshop (ICoVax 2012) was held on October 13, 2013 in Shanghai, China. A number of topics were
presented in the workshop, including allergen predictions, prediction of linear T cell epitopes and functional
conformational epitopes, prediction of protein-ligand binding regions, vaccine design using reverse vaccinology,
and case studies in computational vaccinology. Although a significant progress has been made to date, a number
of challenges still exist in the field. This Editorial provides a list of major challenges for the future of computational
vaccinology and identifies developing themes that will expand and evolve over the next few years.
Introduction and background
Development of effective vaccines for some of the major
infectious diseases contributed to dramatic improve-
ments in public health worldwide over the past 100
years. In the post-genomics and information era, the
application of computational tools to vaccine research
and development (R&D) has contributed to progress in
the development of new vaccines. Computational vacci-
nology is a branch of vaccinology that is focused on
solving scientific questions in vaccinology using computer-
driven algorithms. This interdisciplinary field of research
spans computer science, mathematics, statistics, molecular
biology, microbiology, immunology, and vaccinology.
Computational vaccinology has also been called vaccine
informatics [1]. The two terms are used interchangeably to
represent the same concept at this point in the history of
vaccinology.
Role of immunoinformatics
Computational vaccinology or vaccine informatics is clo-
sely related to immunoinformatics. Many immunoinfor-
matics methods have been developed since 1980s to
predict T-cell immune epitopes and B-cell functional neu-
tralizing or cross-reactive epitopes [2]. These epitopes are
useful for the development of diagnostic tests, for the
development and design of vaccines, and for characteriz-
ing targets of immune responses to vaccines and infec-
tions. A large number of computational algorithms
and software programs have been developed for immune
epitope prediction. In general, T-cell immune epitope pre-
diction can be successful. However, functional B-cell anti-
body epitopes prediction remains a challenge, especially
conformational epitopes [3].
Reverse vaccinology
Computational vaccinology has also contributed to the
“reverse vaccinology” approach to vaccine development.
Reverse vaccinology starts with bioinformatics analysis of
genome or proteome sequences of pathogens [4] and pro-
ceeds “backwards” to identifying critical antigens, rather
than beginning with selection of a single antigen and mov-
ing forward with iterative testing. This comprehensive
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initial screening of genome sequences enables the selec-
tion of antigen candidates that are highly likely to be rele-
vant for vaccine development. An example of successful
reverse vaccinology is the Meningitis B vaccine developed
by Rino Rappuoli’s group (Novartis). This vaccine is under
review by the European Medicines Agency. Approval of
this vaccine would signal the maturation of computational
biology field. A number of other vaccines are in develop-
ment, using reverse vaccinology have also been reported
[1,5].
Vaccinomics and systems vaccinology
Computational vaccinology also relates to “omics” and sys-
tems biology. Specifically, the term “vaccinomics” or
“systems vaccinology” was coined to represent a new field
that integrates immunogenetics and immunogenomics
with “omics-based” systems biology and immune profiling
methods for the better development of next-generation of
vaccines and expansion of personalized medicine studies
[6]. Genome-wide association studies (GWAS) have
shown associations of HLA alleles at various degrees with
persistent infection with hepatitis B virus [7], replication of
HIV-1 [8] and response to MRKAd5 HIV-1 vaccine [9].
With the growth of personal genome and SNP data,
GWAS are expected to delineate host susceptibility factors
in vaccine responses on a more global scale including
populations that are currently underrepresented in
HapMap. Immunoinformatics provides a fundamental set
of tools in the emerging field of systems immunology [10].
Similarly, computational vaccinology is critical to the
advancement of systems vaccinology that must consider
both pathogen and host variability.
Literature mining
Literature mining can be considered as a tool within the
scope of systems vaccinology. Currently, there are over
300,000 vaccine-related peer-reviewed articles cited in the
PubMed literature database [11]. The number of vaccine-
related articles in the database is increasing exponentially
[1]. Vaccine-related literature mining studies have been
reported in vaccine design [12], vaccine-pathogen gene
interactions [13], and vaccine-associated host gene
response discovery [14-16], among others.
Postlicensure vaccine research
Postlicensure vaccine usage and safety surveillance is
another field that has benefitted from computational vac-
cinology [1]. For example, informatics methods have been
used to develop the U.S. Vaccine Adverse Event Reporting
System (VAERS) in the U.S. [17] and the Vaccine Safety
Datalink (VSD) [18] to monitor vaccine safety. Computer-
ized immunization information systems have been devel-
oped to accurately track vaccination history and support
postlicensure vaccine research and safety surveillance [19].
Advances in computational vaccinology
Mathematical modeling of various aspects of infectious
diseases [20] plays an important role in the formation of
immunization program policies [21]. Computational vacci-
nology is contributing to the field of “artificial immune
system”. Further advances in this field may reduce the
need for testing vaccines in animals. A proof of concept
was demonstrated in a pre-clinical study of vaccination
that prevents the development of mammary tumors in
mice [22]. In that study, agent-based mathematical models
were used to determine protective vaccination schedules.
Internet resources for vaccines are abound, however
many of these are focused on the clinical uses and regula-
tory issues related to vaccines [1]. The Vaccine Investigation
and Online Information Network (VIOLIN) a web-based
comprehensive vaccine database and analysis system pri-
marily targeted for vaccine researchers [23]. To promote
vaccine data standardization, integration, and computer-
assisted reasoning, the collaborative, a collaborative effort to
develop a community-based Vaccine Ontology (VO) has
recently been initiated [24]. VO has been shown to support
vaccine data classification [25] and literature mining
[13,14,16].
Advances in computational vaccinology are presented in
a range of scientific meetings. For example, the Interna-
tional Conference on Bioinformatics (InCoB), an Asia
Pacific scientific conference on bioinformatics [26], fre-
quently reports selected computational vaccinology
advances. The International Conference on Artificial
Immune Systems (ICARIS) provides a venue for computa-
tional vaccinologists who are interested in systems-based
approaches to vaccine research. The Immunoinformatics
and Computational Immunology Workshop (ICIW), held
in conjunction with the ACM International Conference on
Bioinformatics and Computational Biology, aims to bridge
the immunology, bioinformatics and computer science [27].
To improve communications between computational
vaccinologists and more traditional vaccine researchers, the
first Computational Vaccinology Workshop was held in
2011 at Seattle, Washington, USA, prior to the 5th Vaccine
& ISV Annual Global Congress. The annual Vaccine &
ISV Annual Global Congress, co-organized by the journal
Vaccine and the International Society for Vaccines (ISV), is
the largest non-commercial conference in the vaccine field
and attended by vaccine experts and researchers around
the world. The second ISV Pre-conference Computational
Vaccinology Workshop (ICoVax 2012) was held on
October 13, 2012, in Shanghai, China [28]. This workshop
occurred one day prior to the sixth Vaccine & ISV Annual
Global Congress.
ICoVax 2012 workshop
ICoVax aspires to become an international forum for
researchers to report, summarize, and discuss the most
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recent developments and ideas in the emerging areas of
computational vaccinology and vaccine informatics, and
to improve our understanding of basic vaccine mechan-
isms and the application of computational tools to vac-
cine development.
The conference was well attended, and fourteen paper
submissions were received and reviewed. Six full-length
papers, five abstracts, and one software demonstration
were accepted for presentation at the workshop. Five
full-length papers were selected for extension and
accepted for publication in a special issue in the journal
BMC Bioinformatics. These papers cover the develop-
ment of new programs and the applications of existing
programs.
Software program development
In the workshop, Wang et al. introduced a comprehensive
evaluation and optimization of sequence-, motif- and
SVM-based computational prediction approaches for aller-
gens [29]. First, the researchers collected a comprehensive
dataset of 989 known allergens and an even larger number
of putative non-allergens. The prediction approaches were
then integrated with this data in a new web-based applica-
tion “proAP” that enhances allergen search and prediction.
Xiang and He introduced the web-based reverse vacci-
nology software program Vaxign [30] for genomics-based
prediction of vaccine targets, and its application in predict-
ing vaccine candidates for herpes simplex virus (HSV)
types 1 and 2 (HSV-1 and HSV-2) [31]. The HSV-1 pro-
tein UL26.5 was predicted to be an adhesin and a promis-
ing candidate for HSV vaccine development. This study
provided an example of Vaxign-based viral vaccine design.
A software demonstration of Vaxign was also conducted
in the workshop.
A major informatics software development topic is 3D
protein structure-based predictions and their applications.
In the workshop, Dr. Zhiwei Cao introduced available
tools in conformational epitope prediction. She also
demonstrated the protein antigen spatial epitope predic-
tion web server (SEPPA), a conformational epitope predic-
tion tool developed by her group [32]. Lo et al. presented
the development of a new method (named “CE-KEG”)
that combines an energy profile for surface residues with
the frequency of each geometrically related amino acid
residue pair to identify possible conformational epitopes
(CEs) in an antigenic protein [33]. This new program
improves the CE identification in immunological studies
and supports synthetic vaccine design. Lo et al. presented
a new approach called PLB-SAVE that uses only geometri-
cal features of proteins and obtained a good overall perfor-
mance for the prediction of protein-ligand binding regions
[34]. PLV-SAVE outperforms two other well-known pre-
diction systems with high accuracy rates and efficient
computational time. PLB-SAVE can be applied to predict
carbohydrate-antibody interactions for further design and
development of carbohydrate-based vaccines.
Three additional software programs were introduced
in the workshop as short talks and/or posters: the soft-
ware program MetaMHCIIpan (a consensus approach
for pan-specific HLA-DR binding predictions) [35],
SAROTUP 2.0 (a suite of web tools for finding potential
target-unrelated peptides from phage display data) [36],
and the iVAX web-based vaccine design program [37].
Applications using available software programs
In this workshop, Chen et al. presented the use of bioin-
formatics tools including the SEPPA spatial epitope pre-
diction program to predict possible cross-reactive spatial
epitopes from norovirus capsid proteins [38]. Two com-
mon epitope regions on the capsid sequences of Group I
and II norovirus genogroups, and an exclusive epitope
region in Group II genogroup were identified. In addition
to this full paper presentation, one short talk and one
poster presentation were made, focusing on application
of EpiMatrix program from EpiVax, Inc. The short talk
by Wei et al. focused on the identification of promiscu-
ous CD4+ T cell epitopes contained within the sequence
of the polyprotein of hand, foot and mouth disease
(HFMD) virus strain EV71 [39]. The most dominant epi-
tope identified in this study is highly conserved in polio-
viruses and other enterovirus species; information
presented in this short talk was recently published as a
paper [40]. Gustiananda et al. analyzed T-cell epitopes
from the envelope proteins of Dengue virus vaccine
strain ChimeriVax and compared them to those from cir-
culating viral strains in Indonesia [41]. Potential cross-
reactivity was identified which might explain the efficacy
(and lack of efficacy) of ChimeriVax against circulating
strains of Dengue virus.
Future challenges and prospects
The studies presented in the ICoVax 2012 workshop
demonstrate the productive efforts in developing and
applying state-of-the-art computational and informatics
methods in the field of computational vaccinology.
While significant progress has been achieved to date,
many challenges still exist in this field.
(1) Challenges in vaccine design
(a) Specific and sensitive prediction of functional B
cell antibody epitopes, in particular the conformational
B cell epitopes. A conformational (or discontinuous)
epitope is an epitope whose residues are distantly
located in the protein sequence but are in physical
proximity in the folded protein. Approximately 90% of
all antibodies are raised against conformational B-cell
antibody epitopes. Since many vaccines require strong
antibody responses, conformational B-cell antibody epi-
tope prediction becomes critical for rational vaccine
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design. While the prediction of non-conformational or
linear epitopes has been proven more difficult than the
prediction of T cell epitopes [42], the prediction of con-
formational B cell functional epitopes is more challen-
ging. The native 3-dimensional (3D) protein structure is
crucial to the prediction of conformational epitopes.
When a 3D protein structure is unknown, the prediction
of the 3D structure often becomes a prerequisite for
conformational epitope prediction. The relations
between conformational epitopes and 3D protein struc-
ture then require further clarification.
(b) Cancer vaccine design. Since the 1950s the develop-
ment of effective cancer vaccines continues to be a chal-
lenge. However, a number of clinical trials have been
delivering promising results that reflect the importance
of broad T cell responses to a range of T cell epitopes
[43]. Further success of cancer vaccine development
mostly requires the identification of antigens that are
unique to cancers, and combining the antigens with an
effective adjuvant and biologics that block regulatory T
cell responses such as anti-CTLA4. This is one area of
translational computational immunology research that is
progressing rapidly to the clinic [44].
(c) Allergy vaccine design. One means of developing
allergy vaccines is to modify allergen molecules with an
aim to reduce both IgE and allergen-specific T cell epitope
responses [45]. Alternatively, T cell epitopes can be admi-
nistered subcutaneously, leading to the induction of anti-
gen-specific tolerance. One company has mapped all of
the sequences of the cat dander allergen Fel d 1 using
immunoinformatics tools and successfully translated this
information into clinical use [46]. Additional vaccines,
developed using immunoinformatics tools, are in clinical
development.
(d) Autoimmune disease vaccine design. Examples of
autoimmune diseases include rheumatoid arthritis,
eczema, and multiple sclerosis. This field is ripe for future
applications of immunoinformatics tools, since in many
cases the autoantigens are known.
(2) Challenges in basic vaccine mechanism studies
(a) Better understanding of fundamental vaccine-
induced protective immunity. Vaccine-induced protective
immunity may be similar to or different from the patho-
gen-induced host immunity. To differentiate these two
types of immune responses is critical to understand pro-
tective immune mechanism.
(b) Identification of immune correlates of protection
and gene markers that predict protective immunity. Until
now, the immune correlates of protection are unknown
for most pathogens. Sufficient and necessary gene mar-
kers for predicting protective immunity are not available
for most pathogens, either. The “omics-based” systems
vaccinology approach has started to provide a powerful
way to detect immune correlates and gene markers of
protection for pathogens including influenza virus [47]
and Yellow fever virus [48,49].
(3) Challenges in post-licensure computational immunology
An electronic health record (EHR) is a collection of
patient health information including clinical date. A
large amount of EHR data from post-licensure vaccine
usage is also available in different immunization registry
systems, vaccine adverse events reporting system, and
clinical information systems. Processing and analysis of
the vaccine-related EHR datasets offers promises of
gaining valuable knowledge but it also presents a chal-
lenge. Many EHR data are unstructured and thus
require some kind of natural language processing (NLP)
to dissect them into structured data. Ontological repre-
sentation and modeling of EHR data can help better
classification and analysis of the vaccine EHR data [50].
New statistical methods are needed to handle the high
throughput EHR data.
(4) Challenges in vaccine databases and data integration
Web-based comprehensive databases are needed to collect
various aspects of vaccine-related data, such as host gene
markers predicting vaccine efficacy and critical pathways
of vaccine-induced immune protection mechanisms. Such
databases are not yet available. While the community-
based Vaccine Ontology aims to support better vaccine
data exchange and automated reasoning, more demonstra-
tions are needed to show the potentials.
(5) Challenges in development of new algorithms and
software programs
Development of novel mathematical, statistical, and com-
putational algorithms and software programs has been a
major task of computational vaccinology. New challenges
and questions require the development and use of more
innovative algorithms and tools than currently available.
These challenges pose new opportunities for research-
ers in computational vaccinology. The field of computa-
tional vaccinology has attracted some of the most
talented researchers from different research areas. We
look forward to more exciting findings and tools coming
out in the near future to support the important vaccine
research and development.
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